MedPath

Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast Cancer

Not Applicable
Recruiting
Conditions
Breast Cancer
Registration Number
NCT04506476
Lead Sponsor
University Hospital Tuebingen
Brief Summary

This randomized three-arm trial will test the benefit in terms of cancer related fatigue of an activity tracker based exercise training during adjuvant radiotherapy in breast cancer patients.

Detailed Description

This monocentric, three-arm, randomized, controlled clinical trial evaluates the effect of an activity tracker based exercise program in breast cancer patients on the fatigue syndrome during adjuvant radiotherapy. Quality of Life and the intensity of fatigue will be documented with the fatigue subscale of the FACIT Questionnaire three months after adjuvant radiotherapy.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
201
Inclusion Criteria
  • Capacity for consent
  • Minimum age 18
  • Presence of breast cancer
  • ECOG 0-2
  • Indication for adjuvant radiotherapy of breast cancer after breast-conserving surgery or Ablatio mammae
Exclusion Criteria
  • Participation in any other interventional study
  • Pregnancy
  • Contraindication against physical activity/sport and others
  • Severe cardiovascular pre-existing conditions (after myocardial infarction, apoplexy in the last 6 months, congestive heart failure NYHA > I°)
  • preexisting diseases with are relevantly accompanied by a limited mobility in patients (e.g. paraparesis of the lower limbs)
  • ECOG Status 3-4
  • prior use of activity trackers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Evaluation of the impact of an activity tracker based fitness programme on the fatigue syndrome3 Months after completion of adjuvant radiotherapy of breast cancer

This endpoint will be evaluated by the FACIT-F (Functional Assessment of Chronic Illness Therapy-Fatigue) subscale of the FACIT questionnaire (Physical well-being values 0-28, 28 worse outcome; social/family well-being values 0-28, 28 better outcome; emotional well-being values 0-24, 24 worse outcome; functional well being values 0-28, 28 better outcome; additional factors values 0-64, 64 worse outcome

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Tübingen, Department of Radiation Oncology

🇩🇪

Tübingen, Baden-Württemberg, Germany

University Hospital Tübingen, Department of Radiation Oncology
🇩🇪Tübingen, Baden-Württemberg, Germany
Daniel Zips, MD, Prof
Contact
+49 (0) 7071 29-85990
ro-info@med.uni-tuebingen.de
Cihan Gani, MD
Contact
+49 (0)7071 29-82165
cihan.gani@med.uni-tuebingen.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.